Margaret Hamburg, M.D.
Co-president, InterAcademy Partnership
Margaret A. Hamburg, MD, Joins NTI as Interim Vice President for NTI | bio
NTI board member Margaret A. Hamburg, MD, is joining NTI’s leadership to serve as interim vice president of the NTI | bio program in February. Hamburg, an internationally recognized leader in public health and medicine, replaces Beth Cameron, PhD, who has moved to the White House to rebuild the National Security Council’s Office of Global Health Security and Biodefense and advance the Biden Administration’s agenda on global health security.
Hamburg’s relationship with NTI goes back to its launch in 2001, when she was named as the organization’s founding senior scientist and biological program vice president. She went on to become commissioner of the Food and Drug Administration and foreign secretary of the National Academy of Medicine.
Hamburg joined NTI’s Board of Directors in 2017.
Stay Informed
Sign up for our newsletter to get the latest on nuclear and biological threats.
More News
NTI Resources on the War in Ukraine
As the war in Ukraine continues, destroying cities and causing the worst humanitarian crisis in Europe in a generation, NTI’s policy experts are fanning out across the news media to discuss the implications of Putin’s actions
NTI | bio Program Officer Chris Isaac Named to 2023 International Strategy Forum as a North America Fellow
NTI | bio Program Officer Chris Isaac has been named to the 2023 International Strategy Forum as a North America Fellow.
NTI at the Munich Security Conference: Advancing Global Nuclear Fail-Safe and Addressing Catastrophic Biological Risks
At this year's Munich Security Conference, NTI is hosting two official side events: one about the importance of global nuclear “fail-safe” measures and one about preventing bioweapons and catastrophic accidents.
